Effect of Cyclooxygenase Activity on Amyloid

About the Research Project
Program
Award Type
Standard
Award Amount
$500,000
Active Dates
August 01, 2004 - July 31, 2007
Grant ID
A2004517
Summary
This study focuses on the effects of an enzyme, cyclo-oxygenase, on amyloid beta, the protein fragment that aggregates into plaques in the brains of Alzheimer’s patients. The process by which amyloid beta accumulates and clumps together to create plaques is not well understood, but scientists think it is central to the development of Alzheimer’s disease. The study may shed light on how non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin and ibuprofen are thought to lower the risk of developing Alzheimer’s disease. NSAIDs are known to inhibit the actions of cyclo-oxygenases, and the scientists believe that if they can succeed in creating a more powerful compound to block cyclo-oxygenase activity, it could lead to a drug that would actually halt the disease. Current Alzheimer’s drugs treat the symptoms, but no drug has been found yet to stop the progression of Alzheimer’s disease.
Related Grants
Alzheimer's Disease Research
Linking Plaque Shapes to Amyloid Structures in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Anllely Fernandez, PhD
Current Organization
Indiana University
Alzheimer's Disease Research
Amyloid Precursor Protein Processing Through a Novel Pathway in Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Justyna Dobrowolska Zakaria, PhD
Current Organization
Northwestern University
Alzheimer's Disease Research
Exploring the Origin and Composition of a Unique Pathology in Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Cyril Pottier, PhD
Current Organization
Washington University in St.Louis